News & Events

Scientists and physicians should advocate to protect the vaccine research infrastructure that has saved an estimated 154 million lives over the past 50 years, according to a new commentary by researchers at Weill Cornell Medicine and the University of Washington.

"Loss of trust in U.S. scientific institutions and ongoing cuts pose an immediate threat to the pipeline of vaccine scientists, and therefore the health and security of citizens, necessitating an urgent response,” said the...

Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse. According to a new preclinical study by Weill Cornell Medicine and MD Anderson Cancer Center investigators, colorectal tumors often find multiple ways to survive treatment, including additional genetic mutations and activation of cellular pathways typically associated with inflammation and regeneration. Targeting this tumor-specific inflammatory process could enhance...

More than 150 educators gathered in person and virtually May 16-17 at Weill Cornell Medicine for the OneCornell Health Educators Conference. The inaugural event, titled: “From Assessment to Feedback: Closing the Loop in Clinical Education in the Health Professions,” convened educators and students from medicine, veterinary medicine, physician assistant studies and licensed veterinary technician training for two days of medical education programming.

The hybrid event was jointly...

A new cardiac magnetic resonance imaging-based measurement may improve how physicians assess a common heart valve condition, according to a study led by Weill Cornell Medicine and NewYork-Presbyterian investigators. The findings support the broader use and further study of the new metric known as effective right ventricular ejection fraction (eRVEF).

In the...

Doctors should consider treating high cholesterol much earlier and more aggressively than they have in the past, according to a new perspective by Weill Cornell Medicine, NewYork-Presbyterian and Yale School of Medicine investigators. The updated 2026 cholesterol management guidelines from the American College of Cardiology and the American Heart Association encourage doctors to identify risk earlier and intervene before...

Underlying cardiovascular risk, rather than older age, drives complications such as venous thromboembolism, cardiomyopathy and heart failure during pregnancy, according to new Weill Cornell Medicine research. The findings may encourage doctors to more actively address cardiovascular health in patients before they become pregnant.

The study, published May 18 in Nature Communications, suggests that instead of pregnancy...

When Dr. Sarah Wozniak was applying to medical schools after completing her undergraduate degree at Rice University, she discovered the Weill Cornell Center for Human Rights, Weill Cornell Medicine’s student-run asylum clinic and the first of its kind at an American medical school.

“I was always...

When Dr. Louisa Schilling was 15 years old, she read a book called “The Brain that Changes Itself,” by Norman Doidge. Her father, who has a doctorate in microbiology and immunology, received it at a conference and it ended up in his daughter’s hands. Her immediate reaction: “I want to study the brain.”

“The...

Dr. Dhruv Khullar, an associate professor of population health sciences and of medicine at Weill Cornell Medicine, has been selected as an Emerging Leader in Health and Medicine (ELHM) Scholar by the National Academy of Medicine.

The program, which launched in 2016, is designed to increase the organization’s engagement with outstanding interdisciplinary early- to mid-career professionals. NAM selects up to 10 people...

Switching to the oral small molecule glucagon-like peptide-1 (GLP-1) orforglipron after taking injectable GLP-1s helped patients maintain most—but not all—of their weight loss, according to a clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

While injectable GLP-1s work well for weight loss, keeping the weight off after discontinuing the therapies is challenging. The results of the...

Over 200 scientists, startup founders and partners in government and industry gathered at Uris Auditorium on April 23 for the 2026 BioInnovate Conference. The event, hosted by BioVenture eLab, part of Weill Cornell Medicine Enterprise Innovation, celebrates the growing ecosystem that turns scientific discovery into scalable healthcare solutions. Speakers and panelists discussed topics ranging from AI in clinical trials to reshoring domestic drug discovery and manufacturing.

Dr. Lisa...

Weill Cornell Medicine-Qatar celebrated its largest ever graduating class, which also includes a record 22 Qatari nationals, during the institution’s commencement ceremony May 5.

The institution awarded U.S.-accredited Cornell University medical degrees to 52 new doctors, hailing from 15 countries, at the ceremony, which was attended by local dignitaries, members of the faculty, and the friends and family of the graduating students. To date, WCM-Q has graduated 693 doctors since its...

All life forms need to continuously adapt to temperature changes to survive. Now, Weill Cornell Medicine investigators studying a bacterial protein have identified a new mechanism of sensing cold temperatures. The finding points to the possibility that this same type of mechanism exists in other organisms, including humans, and may have relevance for disorders involving faulty temperature regulation.

A pilot program aimed at reducing Medicaid drug spending has limitations, according to a multi-institutional research team including faculty from Weill Cornell Medicine.

Launched November 2025, the GENEROUS (GENErating cost Reductions fOr U.S. Medicaid) program asks drug manufacturers to voluntarily reduce Medicaid’s prices to those paid by a group of seven peer nations including Canada, France, and the United Kingdom — a model known as Most Favored Nation pricing. States would then...

Weill Cornell Medicine investigators have “reverse engineered” ketamine’s antidepressant effects to identify potential new strategies for treating depression.

While recreational cannabis laws have significantly reduced arrests for cannabis possession and sales, racial disparities in arrests still exist, according to a new study from Weill Cornell Medicine, Instituto Tecnológico Autónomo de México and The University of Texas at Austin. The authors suggest that recreational cannabis laws do not fully resolve underlying systemic inequities.

The findings,...

Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body’s defense systems, according to a study led by investigators at Weill Cornell Medicine. The discovery extends the scientific understanding of the immune system, identifies a new strategy for boosting immunity against cancers and potentially offers a new tool for delivering genetic payloads to other cells.

Claire Kenney, an M.D.-Ph.D. student, received the Michael O’Dell Trainee Excellence Award from the New York Celtic Medical Society. The society provides a network for Irish-affiliated physicians in New York City.

Dr. Matthew Robbins, the Louis and Rachel Rudin Foundation Education Scholar and a professor of neurology, received the Residency Program Director Recognition Award from American Academy of Neurology. The award...

Rows of poster boards filled the Griffis Faculty Club at Weill Cornell Medicine, showcasing research ranging from cancer immunology and microbiome science to the emerging field of space biology. Standing beside them, graduate students explained months of work in a matter of minutes, fielding questions from judges, faculty and peers.

The 45th annual Vincent du Vigneaud Memorial Research Symposium held on April 16 had a record number of 153 abstracts submitted this year, including...

Nerve fibers within melanomas can slow the growth of these tumors, according to a study led by Weill Cornell Medicine investigators. The findings help clarify the emerging field of cancer neuroscience and may inform future therapeutic strategies.

In the study, published April 29 in Neuron, the researchers used mouse models of the skin cancer melanoma to examine the...